Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS)

CAPS Rating: 1 out of 5

The Company is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel small molecule therapeutics for oncology and other unmet medical needs.

Recs

0
Player Avatar pchop123 (76.58) Submitted: 6/25/2012 10:37:47 AM : Outperform Start Price: $2.59 SNSS Score: +11.02

Will go UP, it just is a matter of when

Featured Broker Partners


Advertisement